Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 7 of 7 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Propella Therapeutics Inc. | Activity: Research and Development | Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. | Location Pittsboro | |
Company Amalgent Therapeutics Inc. | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing novel pain management therapeutics for the treatment of pain without addiction. | Location Greenville | |
Company Ardeal Pharma Inc. | Activity: Research and Development | Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. | Location Brevard | |
Company Ardeal Research Institute | Activity: Research and Development | Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. | Location Brevard | |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville | |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville | |
Company Fervent Pharmaceuticals LLC | Activity: Research and Development | Company Description Fervent Pharmaceuticals develops a nonhormonal product, FP-101, to treat vasomotor symptoms associated with menopause. | Location Greenville |